FVB(Cg)-Airntm1Dpb Del(17Airn-Igf2r)/Biat

Status

Available to order

EMMA IDEM:09899
Citation informationRRID:IMSR_EM:09899 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameFVB(Cg)-Airntm1Dpb Del(17Airn-Igf2r)/Biat
Alternative nameFVB.129P2-AIDel
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolAirntm1Dpb, Del(17Airn-Igf2r)
Gene/Transgene symbolAirn, Del(17Airn-Igf2r)

Information from provider

ProviderDenise Barlow
Provider affiliationCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Genetic informationThe AIDel allele has a 28kb deletion on chromosome 17 between 3kb downstream of the Airn transcription start site (TSS) (Igf2r intron 2) and 2.8kb upstream of the Igf2r TSS (GRCm38/mm10, chr17: 12,744,358 -12,772,513). Additionally, Airn is truncated by a polyadenylation cassette immediately before the AIDel deletion. This allele was made by chromosome engineering by targeted meiotic recombination (Herault et al. 1998, Nature Genetics; 20:381–384), by breeding together the Airn truncation allele (FVB.129P2-AirnT, Sleutels et al. 2002, Nature; 415:810-813) and the Igf2r promoter deletion (FVB.129P2-IPD, Sleutels et al. 2003, EMBO J.; 22:3696-3704) with Hprt1-cre (B6.129S1-Hprt1-cre, Tang et al. 2002, Genesis; 32:199-202), and screening the offspring of triple mutant males for recombination events. The AIDel allele should have a 129P2 background near the deletion, and a B6/FVB mixed background in other regions of the genome. The background should be closer to FVB as the mice have been backcrossed to FVB/N for 3 generations.
Phenotypic informationHomozygous:
Homozygous mice should be embryonic lethal between E13.5 and E18.5 due to deletion of the Igf2r promoter (Barlow et al. 1991, Nature).

Heterozygous:
Heterozygotes with a maternally inherited AIDel allele should be embryonic lethal between E13.5 and E18.5 due to deletion of the Igf2r promoter, while mice with a paternal inheritance of the duplication are viable and fertile.
Breeding historyAIDel mice were derived over 2 generations by breeding together FVB.129P2-AirnT, FVB.129P2-IPD and B6.129S1-Hprt1-cre mice, and then screening the offspring of triple mutant males for recombination events, as described in the “Genetic Description” section. The AIDel founder was then backcrossed to FVB/N for 3 generations.
ReferencesNone available
Homozygous fertileno
Homozygous viableno
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreUniversity of Veterinary Medicine, Vienna, Austria
Animals used for archivingheterozygous FVB.129P2/OlaHsd males

Disease and phenotype information

MGI phenotypes (allele matching)
  • abnormal postnatal growth/weight/body size / MGI
  • maternal imprinting / MGI
  • decreased body weight / MGI
MGI phenotypes (gene matching)
  • decreased body weight / MGI
  • reduced female fertility / MGI
  • abnormal postnatal growth/weight/body size / MGI
  • maternal imprinting / MGI
  • maternal effect / MGI
  • reproductive system phenotype / MGI
  • abnormal DNA methylation / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).